Conditions: Diabetes Mellitus, Type 2
Allocation:  | Intervention model: PARALLEL
Enrollment: 408
Healthy volunteers: no

Brief summary:
The objective is to investigate the efficacy, safety and pharmacokinetics of three different doses of BI 10773 compared to placebo given for 12 weeks in patients with type 2 diabetes mellitus with insufficient glycemic control. In addition an open-label metformin arm will be assessed

Detailed description:

Arms:

Interventions: intervention 1: BI 10773 intervention 2: placebo intervention 3: metformin
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: